A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)
Clinical trial NCT04871997 · COMPLETED
Trial details
- NCT number
- NCT04871997
- Sponsor
- Qian Chu
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-07-12
- Primary completion
- 2022-07-16
- Enrollment
- 373
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.